Andrew R. Robbins
2018
In 2018, Andrew R. Robbins earned a total compensation of $3.2M as Chief Operating Officer at Array BioPharma, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $257,528 |
|---|---|
| Option Awards | $1,861,648 |
| Salary | $446,456 |
| Stock Awards | $610,155 |
| Other | $37,722 |
| Total | $3,213,509 |
Robbins received $1.9M in option awards, accounting for 58% of the total pay in 2018.
Robbins also received $257.5K in non-equity incentive plan, $446.5K in salary, $610.2K in stock awards and $37.7K in other compensation.
Rankings
In 2018, Andrew R. Robbins' compensation ranked 3,588th out of 14,244 executives tracked by ExecPay. In other words, Robbins earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,588 out of 14,244 | 75th |
Division Manufacturing | 1,324 out of 5,765 | 77th |
Major group Chemicals And Allied Products | 467 out of 2,128 | 78th |
Industry group Drugs | 386 out of 1,817 | 79th |
Industry Pharmaceutical Preparations | 297 out of 1,391 | 79th |
Source: SEC filing on September 14, 2018.
Robbins' colleagues
We found four more compensation records of executives who worked with Andrew R. Robbins at Array BioPharma in 2018.